EyePoint Pharmaceuticals, Inc. financial data

Symbol
EYPT on Nasdaq
Industry
Laboratory Analytical Instruments
Location
480 Pleasant Street, Suite B300, Watertown, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
pSivida Corp. (to 3/30/2018), pSivida LTD (to 6/18/2008)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 518 % +58.4%
Quick Ratio 6.18 % -23.8%
Debt-to-equity 36 % -72.5%
Return On Equity -43 % +68.8%
Return On Assets -31.6 % +47%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 68.3M shares +93.3%
Common Stock, Shares, Outstanding 53.5M shares +51.6%
Entity Public Float 233M USD +11.2%
Common Stock, Value, Issued 53K USD +51.4%
Weighted Average Number of Shares Outstanding, Basic 54.4M shares +42%
Weighted Average Number of Shares Outstanding, Diluted 54.4M shares +42%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 45.7M USD +7.5%
Research and Development Expense 107M USD +72.6%
Selling and Marketing Expense 6.26M USD -64.1%
General and Administrative Expense 51.1M USD +36.7%
Costs and Expenses 43.3M USD +46.2%
Operating Income (Loss) -117M USD -14.2%
Nonoperating Income (Expense) 13.5M USD +485%
Net Income (Loss) Attributable to Parent -104M USD -3.42%
Earnings Per Share, Basic -1.99 USD/shares +25.5%
Earnings Per Share, Diluted -1.99 USD/shares +25.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 79.8M USD -40%
Marketable Securities, Current 174M USD +5744%
Cash, Cash Equivalents, and Short-term Investments 254M USD +86.6%
Inventory, Net 2.81M USD -38.7%
Other Assets, Current 1.3M USD +136%
Assets, Current 269M USD +78.8%
Property, Plant and Equipment, Net 8.39M USD +87.3%
Operating Lease, Right-of-Use Asset 21.4M USD +308%
Other Assets, Noncurrent 2.42M USD
Assets 301M USD +88%
Accounts Payable, Current 7.34M USD -23.4%
Employee-related Liabilities, Current 8.91M USD +5.2%
Accrued Liabilities, Current 14.2M USD +5.58%
Liabilities, Current 48.8M USD -23.6%
Operating Lease, Liability, Noncurrent 21.9M USD +323%
Other Liabilities, Noncurrent 233K USD
Liabilities 82.2M USD -19%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.17M USD +39.2%
Retained Earnings (Accumulated Deficit) -832M USD -14.2%
Stockholders' Equity Attributable to Parent 219M USD +273%
Liabilities and Equity 301M USD +88%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -31.2M USD -85.2%
Net Cash Provided by (Used in) Financing Activities 115K USD
Net Cash Provided by (Used in) Investing Activities 20.8M USD -35.2%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 53.5M shares +51.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -10.3M USD -201%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 80M USD -39.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 146M USD +17.3%
Deferred Tax Assets, Gross 148M USD +16.9%
Operating Lease, Liability 23.1M USD +270%
Depreciation 303K USD +189%
Payments to Acquire Property, Plant, and Equipment 1.19M USD +147%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -103M USD -3.28%
Lessee, Operating Lease, Liability, to be Paid 47.7M USD +568%
Property, Plant and Equipment, Gross 7.82M USD +126%
Operating Lease, Liability, Current 1.19M USD +12.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.13M USD +177%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.59M USD +158%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure +103%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 24.6M USD +2614%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.22M USD +166%
Deferred Tax Assets, Operating Loss Carryforwards 82.6M USD -6.76%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.32M USD +103%
Operating Lease, Payments 274K USD +67.1%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 0 USD -100%
Share-based Payment Arrangement, Expense 32.4M USD +174%
Interest Expense 0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%